Jiawei Chen Selected Research

CT 77

1/2021

In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiawei Chen Research Topics

Disease

40	Neoplasms (Cancer) 09/2022 - 04/2008
16	Atherosclerosis 08/2013 - 07/2003
13	Inflammation (Inflammations) 07/2022 - 06/2006
10	Hypoxia (Hypoxemia) 01/2022 - 10/2011
10	Breast Neoplasms (Breast Cancer) 07/2021 - 01/2015
7	Carcinogenesis 03/2022 - 01/2014
7	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2013
5	Infections 01/2022 - 10/2008
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2014
5	Fibrosis (Cirrhosis) 01/2021 - 01/2013
4	Diabetes Mellitus 12/2021 - 01/2018
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 04/2012
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2012
4	Glioma (Gliomas) 12/2019 - 01/2018
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2018 - 04/2011
3	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 01/2018
3	Triple Negative Breast Neoplasms 01/2022 - 11/2016
3	Hypertension (High Blood Pressure) 01/2022 - 11/2004
3	Dyslipidemias (Dyslipidemia) 03/2021 - 10/2004
3	Hyperglycemia 01/2021 - 02/2012
3	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 07/2011
2	Ototoxicity 06/2022 - 01/2022
2	Postoperative Pain 01/2022 - 07/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2021
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 12/2018
2	Nasopharyngeal Carcinoma 12/2021 - 01/2020
2	Body Weight (Weight, Body) 03/2021 - 01/2021
2	Meningioma (Meningiomas) 01/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2012
2	Cystitis 10/2017 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2017 - 01/2016
2	Malignant Fibrous Histiocytoma 01/2017 - 11/2016
2	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 03/2013
2	Endometrial Neoplasms (Endometrial Cancer) 04/2013 - 04/2008
2	Atherosclerotic Plaque (Atheroma) 07/2008 - 02/2008
2	Endometrioid Carcinoma 05/2008 - 04/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 08/2006 - 09/2005
2	Ischemia 08/2006 - 11/2004

Drug/Important Bio-Agent (IBA)

12	Propofol (Diprivan)FDA LinkGeneric 01/2022 - 02/2012
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
9	CytokinesIBA 01/2022 - 01/2006
9	oxidized low density lipoproteinIBA 09/2007 - 07/2003
8	Pharmaceutical PreparationsIBA 06/2022 - 01/2013
7	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 01/2018
6	CholesterolIBA 01/2022 - 10/2004
6	Messenger RNA (mRNA)IBA 11/2019 - 01/2016
6	Angiotensin IIIBA 12/2018 - 11/2004
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 11/2013
5	CollagenIBA 01/2017 - 10/2006
4	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 02/2017
4	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2017
4	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2018
3	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2021
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 10/2004
3	Long Noncoding RNAIBA 12/2021 - 01/2017
3	Oxygen (Dioxygen)IBA 05/2021 - 05/2016
3	LigandsIBA 12/2019 - 12/2003
3	Interleukin-10 (Interleukin 10)IBA 12/2019 - 09/2006
3	Insulin (Novolin)FDA Link 01/2018 - 08/2006
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 04/2008
3	Inhibitor of Apoptosis ProteinsIBA 07/2013 - 01/2012
3	SurvivinIBA 07/2013 - 01/2012
2	Small Interfering RNA (siRNA)IBA 09/2022 - 04/2011
2	Carrier Proteins (Binding Protein)IBA 09/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2018
2	LuciferasesIBA 01/2022 - 01/2018
2	Tigecycline (Tygacil)FDA Link 01/2022 - 01/2021
2	Sirtuin 1IBA 01/2022 - 12/2021
2	AntioxidantsIBA 01/2022 - 10/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 10/2008
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2021 - 04/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2011
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2013
2	EnzymesIBA 01/2021 - 10/2017
2	6-methyladenineIBA 01/2021 - 12/2020
2	IntegrinsIBA 01/2020 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2020
2	CalciumIBA 01/2020 - 07/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2013
2	Biological ProductsIBA 01/2019 - 08/2013
2	EpitopesIBA 01/2019 - 01/2018
2	Ketamine FDA LinkGeneric 10/2017 - 01/2017
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2016 - 06/2006
2	HomocysteineIBA 03/2014 - 04/2012
2	5' Untranslated Regions (5' UTR)IBA 07/2013 - 05/2012
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2012 - 08/2008
2	Type 2 Angiotensin ReceptorIBA 08/2008 - 02/2008
2	LDL Receptors (LDL Receptor)IBA 07/2008 - 09/2005
2	LectinsIBA 09/2007 - 02/2006
2	Scarlet Red (Sudan IV)IBA 09/2006 - 02/2006
2	PPAR gammaIBA 08/2006 - 12/2003
2	Rosuvastatin Calcium (Crestor)FDA Link 02/2006 - 10/2004
2	candesartanIBA 02/2006 - 10/2004
2	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2006 - 01/2006

Therapy/Procedure

13	Therapeutics 09/2022 - 01/2014
4	Radiotherapy 12/2021 - 10/2017
3	Drug Therapy (Chemotherapy) 06/2022 - 10/2014
2	Brachytherapy 07/2018 - 10/2017